BusinessUniversity of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia SurgeryBy Nasdaq OMXFeb 27, 2018, 12:30 PM UTC
BusinessCBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid AddictionBy Nasdaq OMXFeb 21, 2018, 2:01 PM UTC
BusinessDr. Paul Carney Joins Biotica Pharmaceuticals as Neurologist Consultant and Scientific AdvisorBy Nasdaq OMXJan 3, 2018, 1:00 PM UTC
BusinessPraxis Bioresearch Presents Positive Preclinical Data for Novel Prodrug Stimulant with Abuse-Deterrent Properties at ACNP Annual MeetingBy Nasdaq OMXDec 7, 2017, 12:35 PM UTC
BusinessA New Program at Yale Takes Aim at Opioid and other Substance Abuse using EntrepreneurshipBy Nasdaq OMXNov 15, 2017, 3:55 PM UTC
BusinessAIR Experts to Present at the American Public Health Association (APHA) Annual MeetingBy Nasdaq OMXNov 2, 2017, 2:16 PM UTC
BusinessCB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health EmergencyBy Nasdaq OMXOct 31, 2017, 12:00 PM UTC
BusinessStatement by U.S. Conference of Mayors President and New Orleans Mayor Mitch Landrieu on President Trump’s Announcement About Opioid EpidemicBy Nasdaq OMXOct 26, 2017, 9:02 PM UTC
